Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Vectors | 15 | 2004 | 970 | 1.020 |
Why?
|
| Liver | 18 | 2000 | 1879 | 0.980 |
Why?
|
| Visual Cortex | 5 | 2025 | 131 | 0.830 |
Why?
|
| Retroviridae | 11 | 2004 | 198 | 0.670 |
Why?
|
| Genetic Therapy | 13 | 2004 | 737 | 0.540 |
Why?
|
| Promoter Regions, Genetic | 10 | 1998 | 1433 | 0.520 |
Why?
|
| alpha 1-Antitrypsin | 10 | 1997 | 85 | 0.490 |
Why?
|
| Hepatocyte Growth Factor | 3 | 2000 | 38 | 0.360 |
Why?
|
| Transfection | 6 | 1996 | 1096 | 0.320 |
Why?
|
| Transduction, Genetic | 5 | 1999 | 296 | 0.310 |
Why?
|
| Moloney murine leukemia virus | 4 | 1996 | 18 | 0.280 |
Why?
|
| Models, Neurological | 2 | 2025 | 220 | 0.260 |
Why?
|
| Connectome | 2 | 2025 | 118 | 0.260 |
Why?
|
| Mucopolysaccharidosis VII | 2 | 2004 | 3 | 0.230 |
Why?
|
| Glucuronidase | 2 | 2004 | 32 | 0.230 |
Why?
|
| Color Vision | 1 | 2024 | 11 | 0.230 |
Why?
|
| beta-Galactosidase | 3 | 1996 | 151 | 0.220 |
Why?
|
| Spleen | 3 | 2000 | 292 | 0.210 |
Why?
|
| Photic Stimulation | 4 | 2025 | 234 | 0.200 |
Why?
|
| Color | 1 | 2022 | 35 | 0.200 |
Why?
|
| Neurons | 4 | 2025 | 2050 | 0.200 |
Why?
|
| Reflex, Pupillary | 1 | 2022 | 16 | 0.200 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 4 | 1996 | 373 | 0.200 |
Why?
|
| Gene Expression Regulation | 5 | 1999 | 2669 | 0.200 |
Why?
|
| Pupil | 1 | 2022 | 57 | 0.190 |
Why?
|
| Rats | 12 | 1999 | 3890 | 0.190 |
Why?
|
| Vision, Ocular | 1 | 2022 | 133 | 0.180 |
Why?
|
| Animals | 25 | 2025 | 36557 | 0.170 |
Why?
|
| Mice | 15 | 2025 | 19055 | 0.170 |
Why?
|
| Lysosomes | 2 | 2004 | 265 | 0.160 |
Why?
|
| Transcription Factor AP-1 | 1 | 1999 | 112 | 0.160 |
Why?
|
| Protein C | 1 | 1998 | 21 | 0.150 |
Why?
|
| Lipopolysaccharides | 1 | 1999 | 319 | 0.140 |
Why?
|
| Factor X Deficiency | 1 | 1997 | 1 | 0.140 |
Why?
|
| Factor X | 1 | 1997 | 4 | 0.140 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1996 | 60 | 0.130 |
Why?
|
| Gene Transfer Techniques | 1 | 1998 | 365 | 0.130 |
Why?
|
| Genes, ras | 1 | 1996 | 102 | 0.130 |
Why?
|
| Cyclins | 1 | 1996 | 105 | 0.130 |
Why?
|
| Adenoviridae | 1 | 1999 | 609 | 0.130 |
Why?
|
| ras Proteins | 1 | 1996 | 146 | 0.120 |
Why?
|
| Apolipoproteins E | 1 | 1996 | 204 | 0.120 |
Why?
|
| Base Sequence | 5 | 2000 | 3180 | 0.110 |
Why?
|
| Liver Regeneration | 4 | 1999 | 41 | 0.110 |
Why?
|
| Cell Division | 3 | 2000 | 774 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2004 | 806 | 0.110 |
Why?
|
| Dendrites | 2 | 2025 | 204 | 0.100 |
Why?
|
| Animals, Newborn | 2 | 2004 | 1044 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 5 | 2024 | 4879 | 0.100 |
Why?
|
| Tumor Suppressor Proteins | 1 | 1994 | 510 | 0.090 |
Why?
|
| Gene Expression | 3 | 1994 | 1621 | 0.090 |
Why?
|
| Hepatectomy | 4 | 1996 | 124 | 0.090 |
Why?
|
| Neoplasm Proteins | 1 | 1994 | 719 | 0.080 |
Why?
|
| Liposomes | 1 | 1991 | 207 | 0.080 |
Why?
|
| Molecular Sequence Data | 4 | 1996 | 3980 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 5 | 1999 | 1310 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 1 | 1994 | 1167 | 0.070 |
Why?
|
| Acute-Phase Proteins | 2 | 1999 | 50 | 0.070 |
Why?
|
| Cells, Cultured | 4 | 1996 | 3188 | 0.070 |
Why?
|
| 3T3 Cells | 2 | 1997 | 127 | 0.070 |
Why?
|
| RNA Polymerase II | 3 | 1996 | 102 | 0.060 |
Why?
|
| Male | 10 | 2025 | 66127 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 1997 | 2915 | 0.060 |
Why?
|
| Color Perception | 1 | 2024 | 12 | 0.060 |
Why?
|
| Orientation | 1 | 2024 | 47 | 0.060 |
Why?
|
| Primates | 1 | 2024 | 87 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 2 | 1996 | 322 | 0.050 |
Why?
|
| Visual Pathways | 1 | 2024 | 85 | 0.050 |
Why?
|
| Liver Transplantation | 3 | 1992 | 1128 | 0.050 |
Why?
|
| Visual Fields | 1 | 2024 | 147 | 0.050 |
Why?
|
| Darkness | 1 | 2022 | 27 | 0.050 |
Why?
|
| DNA | 2 | 1999 | 1682 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 2 | 1994 | 261 | 0.050 |
Why?
|
| Binding Sites | 2 | 1996 | 1384 | 0.050 |
Why?
|
| Axons | 1 | 2025 | 397 | 0.050 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2022 | 88 | 0.050 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2022 | 79 | 0.050 |
Why?
|
| Ultraviolet Rays | 1 | 2022 | 208 | 0.050 |
Why?
|
| Synapses | 1 | 2025 | 469 | 0.040 |
Why?
|
| Dogs | 4 | 2004 | 798 | 0.040 |
Why?
|
| DNA-Binding Proteins | 3 | 1999 | 2178 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 94 | 0.040 |
Why?
|
| DNA Primers | 1 | 2000 | 672 | 0.040 |
Why?
|
| Cell Movement | 2 | 1995 | 920 | 0.040 |
Why?
|
| Drug Synergism | 1 | 1999 | 242 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 115 | 0.040 |
Why?
|
| Bromodeoxyuridine | 1 | 1999 | 59 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 1999 | 198 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 1999 | 212 | 0.040 |
Why?
|
| Rats, Inbred Lew | 1 | 1998 | 70 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 1999 | 271 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 1999 | 231 | 0.030 |
Why?
|
| Serum Albumin | 2 | 1994 | 117 | 0.030 |
Why?
|
| Humans | 13 | 2000 | 134156 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 1995 | 2539 | 0.030 |
Why?
|
| NF-kappa B | 1 | 1999 | 482 | 0.030 |
Why?
|
| Diethylnitrosamine | 1 | 1996 | 17 | 0.030 |
Why?
|
| Glucose-6-Phosphatase | 1 | 1996 | 18 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1996 | 92 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 1996 | 109 | 0.030 |
Why?
|
| Portal Vein | 1 | 1996 | 95 | 0.030 |
Why?
|
| Alanine Transaminase | 1 | 1996 | 162 | 0.030 |
Why?
|
| Toxins, Biological | 1 | 1996 | 71 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1997 | 472 | 0.030 |
Why?
|
| Carcinogens | 1 | 1996 | 160 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1997 | 443 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1996 | 272 | 0.030 |
Why?
|
| Galactosides | 1 | 1995 | 11 | 0.030 |
Why?
|
| Albumins | 1 | 1996 | 99 | 0.030 |
Why?
|
| Phosphorylation | 1 | 1999 | 1713 | 0.030 |
Why?
|
| Fluoresceins | 1 | 1995 | 36 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 98 | 0.030 |
Why?
|
| Trans-Activators | 1 | 1999 | 840 | 0.030 |
Why?
|
| Fatty Acid-Binding Protein 7 | 1 | 1994 | 2 | 0.030 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 1994 | 10 | 0.030 |
Why?
|
| Methylation | 1 | 1995 | 232 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 1994 | 45 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 1994 | 32 | 0.030 |
Why?
|
| Cell Separation | 1 | 1995 | 234 | 0.030 |
Why?
|
| DNA, Viral | 1 | 1996 | 500 | 0.030 |
Why?
|
| Proviruses | 1 | 1994 | 18 | 0.030 |
Why?
|
| Indoles | 1 | 1995 | 203 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 1107 | 0.030 |
Why?
|
| RNA, Viral | 1 | 1996 | 563 | 0.030 |
Why?
|
| Gene Dosage | 1 | 1995 | 458 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 1995 | 837 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 1994 | 398 | 0.020 |
Why?
|
| Biopsy | 1 | 1996 | 1304 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 1996 | 1765 | 0.020 |
Why?
|
| Fatty Acids | 1 | 1994 | 372 | 0.020 |
Why?
|
| Female | 3 | 2025 | 71928 | 0.020 |
Why?
|
| Time Factors | 1 | 2022 | 6610 | 0.020 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 1992 | 37 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2004 | 2090 | 0.020 |
Why?
|
| Fibroblasts | 1 | 1996 | 928 | 0.020 |
Why?
|
| Tissue Transplantation | 1 | 1991 | 11 | 0.020 |
Why?
|
| Transplantation, Heterotopic | 1 | 1991 | 29 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 1991 | 98 | 0.020 |
Why?
|
| Splenectomy | 1 | 1991 | 63 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1991 | 186 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1991 | 367 | 0.020 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1991 | 136 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 1994 | 1627 | 0.020 |
Why?
|
| Apoptosis | 1 | 1996 | 1946 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1994 | 1077 | 0.020 |
Why?
|
| Transcription Factors | 2 | 1996 | 2738 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1996 | 2137 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1992 | 1440 | 0.020 |
Why?
|
| Signal Transduction | 1 | 1999 | 4934 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1996 | 1007 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1991 | 1027 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1991 | 1761 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1996 | 1417 | 0.010 |
Why?
|
| beta-N-Acetylhexosaminidases | 1 | 2004 | 10 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 2004 | 35 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2004 | 252 | 0.010 |
Why?
|
| Dog Diseases | 1 | 2004 | 60 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2004 | 245 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 2004 | 181 | 0.010 |
Why?
|
| Mitral Valve | 1 | 2004 | 272 | 0.010 |
Why?
|
| Aortic Valve | 1 | 2004 | 469 | 0.010 |
Why?
|
| Aorta | 1 | 2004 | 564 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2004 | 1004 | 0.010 |
Why?
|
| Myocytes, Cardiac | 1 | 2004 | 676 | 0.010 |
Why?
|
| Myocardium | 1 | 2004 | 1046 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 1994 | 50 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 4808 | 0.010 |
Why?
|
| Retroviridae Proteins | 1 | 1992 | 12 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 1992 | 286 | 0.010 |
Why?
|
| Forecasting | 1 | 1992 | 377 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1992 | 451 | 0.010 |
Why?
|
| Cell Survival | 1 | 1992 | 890 | 0.000 |
Why?
|
| Nuclear Proteins | 1 | 1994 | 1351 | 0.000 |
Why?
|
| Models, Biological | 1 | 1992 | 1539 | 0.000 |
Why?
|
| Phenotype | 1 | 1992 | 4598 | 0.000 |
Why?
|